- Home
- Publications
- Publication Search
- Publication Details
Title
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-03-07
DOI
10.3389/fphys.2018.00167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranulation of human neutrophils in vitro
- (2017) Nina Vorobjeva et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Mast Cells MASTers in Cancer?
- (2017) Gilda Varricchi et al. Frontiers in Immunology
- European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
- (2017) Javier Egea et al. Redox Biology
- From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
- (2017) Carlo Gabriele Tocchetti et al. ANTIOXIDANTS & REDOX SIGNALING
- Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema
- (2016) S. Loffredo et al. ALLERGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TAS-102, the first “cardio-gentle” fluoropyrimidine in the colorectal cancer landscape?
- (2016) Fausto Petrelli et al. BMC CANCER
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Controversial role of mast cells in skin cancers
- (2016) Gilda Varricchi et al. EXPERIMENTAL DERMATOLOGY
- Current views on anthracycline cardiotoxicity
- (2016) Donato Mele et al. HEART FAILURE REVIEWS
- Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
- (2016) Valentina Mercurio et al. JOURNAL OF CARDIAC FAILURE
- Preventing antiblastic drug-related cardiomyopathy
- (2016) Christian Cadeddu et al. Journal of Cardiovascular Medicine
- Pathophysiology of anthracycline cardiotoxicity
- (2016) Donato Mele et al. Journal of Cardiovascular Medicine
- Role of biomarkers in monitoring antiblastic cardiotoxicity
- (2016) Giuseppina Novo et al. Journal of Cardiovascular Medicine
- Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane
- (2016) Olga Lenčová-Popelová et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function
- (2016) Gonçalo C. Pereira et al. MITOCHONDRION
- Combination chemoprevention with grape antioxidants
- (2016) Chandra K. Singh et al. MOLECULAR NUTRITION & FOOD RESEARCH
- NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
- (2016) Jong-Seok Moon et al. NATURE MEDICINE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology
- (2016) Alessia Arcaro et al. Oxidative Medicine and Cellular Longevity
- Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
- (2016) Subrata Kumar Biswas Oxidative Medicine and Cellular Longevity
- VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
- (2016) Markus Räsänen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immune network in thyroid cancer
- (2016) Maria Rosaria Galdiero et al. OncoImmunology
- Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer
- (2016) Annelies H. Boekhout et al. JAMA Oncology
- ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
- (2015) Frances Belmonte et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Redox signalling and cardioprotection: translatability and mechanism
- (2015) P Pagliaro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacology of the ‘gasotransmitters’ NO, CO and H2S: translational opportunities
- (2015) Andreas Papapetropoulos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function
- (2015) Runyawan Chotenimitkhun et al. CANADIAN JOURNAL OF CARDIOLOGY
- Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways
- (2015) Polina Sysa-Shah et al. CARDIOVASCULAR RESEARCH
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
- (2015) Carlo Tocchetti et al. CURRENT DRUG TARGETS
- Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction
- (2015) Shir Lynn Lim et al. EUROPEAN HEART JOURNAL
- Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications
- (2015) Thomas Münzel et al. EUROPEAN HEART JOURNAL
- Oxidative stress alters global histone modification and DNA methylation
- (2015) Yingmei Niu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
- (2015) Rosalinda Madonna et al. HEART FAILURE REVIEWS
- Cardioprotection by gene therapy
- (2015) Rosalinda Madonna et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS and RNS in plant physiology: an overview
- (2015) Luis A. del Río JOURNAL OF EXPERIMENTAL BOTANY
- Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
- (2015) Rosaria I. Staiano et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Intracoronary Cytoprotective Gene Therapy
- (2015) Felix Woitek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation
- (2015) Gabriele D’Uva et al. NATURE CELL BIOLOGY
- Chronic heart damage following doxorubicin treatment is alleviated by lovastatin
- (2015) Christian Henninger et al. PHARMACOLOGICAL RESEARCH
- Cancer after intense and prolonged antiplatelet therapies – fact or fiction?
- (2015) Raffaele De Caterina THROMBOSIS AND HAEMOSTASIS
- Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
- (2015) Marilisa Molinaro et al. Biomed Research International
- Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair
- (2015) Yuliya Mikhed et al. Redox Biology
- Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors
- (2015) Amy A. Kirkham et al. Journal of Oncology
- Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk
- (2014) C. Lestuzzi et al. ANNALS OF ONCOLOGY
- New Redox-Related Arrows in the Arsenal of Cardiac Disease Treatment
- (2014) Jonathan A. Kirk et al. ANTIOXIDANTS & REDOX SIGNALING
- Cardiotoxicity of systemic agents used in breast cancer
- (2014) Felipe Ades et al. BREAST
- Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients
- (2014) Frederik J. F. Broeyer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Angiogenesis and Cardiac Hypertrophy
- (2014) Toru Oka et al. CIRCULATION RESEARCH
- VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
- (2014) Riikka Kivelä et al. EMBO Molecular Medicine
- Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction
- (2014) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Protein S-nitrosylation in preconditioning and postconditioning
- (2014) Claudia Penna et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
- (2014) Giuseppe Bronte et al. Expert Opinion On Drug Safety
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial reactive oxygen species production and elimination
- (2014) Alexander Nickel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach
- (2014) Matteo Zanardelli et al. PLoS One
- A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives
- (2014) Monica Lamberti et al. TOXICOLOGY LETTERS
- Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure
- (2014) Cristi L. Galindo et al. Journal of the American Heart Association
- Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
- (2014) Virginia Shalkey Hahn et al. Journal of the American Heart Association
- The role of iron in anthracycline cardiotoxicity
- (2014) Elena Gammella et al. Frontiers in Pharmacology
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Redox-Optimized ROS Balance and the relationship between mitochondrial respiration and ROS
- (2013) Sonia Cortassa et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The role of antioxidants in the era of cardio-oncology
- (2013) Duncan T. Vincent et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
- (2013) Anne Polk et al. CANCER TREATMENT REVIEWS
- 5-fluorouracil induced cardiotoxicity: Review of the literature
- (2013) Michael F. Sorrentino et al. Cardiology Journal
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
- (2013) Sinziana Seicean et al. Circulation-Heart Failure
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors
- (2013) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- The beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy
- (2013) Zhe Jin et al. Journal of Cardiology
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart
- (2013) Zoltán V. Varga et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
- (2013) Xavier Bosch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
- (2013) Thomas E Hutson et al. LANCET ONCOLOGY
- Anthracyclines and Heart Failure
- (2013) Douglas B. Sawyer NEW ENGLAND JOURNAL OF MEDICINE
- Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?
- (2013) Monte S. Willis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2013) S. M. Swain et al. ONCOLOGIST
- Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity
- (2013) Ashish Gupta et al. PLoS One
- Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity
- (2013) V. Chintalgattu et al. Science Translational Medicine
- Exercise Therapy as Treatment for Cardiovascular and Oncologic Disease After a Diagnosis of Early-Stage Cancer
- (2013) Jessica M. Scott et al. SEMINARS IN ONCOLOGY
- Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
- (2013) Mariele Dessì et al. SpringerPlus
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- NADPH Oxidases in Heart Failure: Poachers or Gamekeepers?
- (2012) Min Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway
- (2012) Yongwei Yao et al. BASIC RESEARCH IN CARDIOLOGY
- Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
- (2012) Peter P. Rainer et al. BJU INTERNATIONAL
- Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury
- (2012) Xiaohui Wang et al. CARDIOVASCULAR RESEARCH
- Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
- (2012) Rui Chen et al. CELL
- Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy
- (2012) Raffaele Coppini et al. CIRCULATION
- Neuregulin in Cardiovascular Development and Disease
- (2012) Oghenerukevwe Odiete et al. CIRCULATION RESEARCH
- Biomarkers of Protein Oxidation in Human Disease
- (2012) A. Garcia-Garcia et al. CURRENT MOLECULAR MEDICINE
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
- (2012) Mehmet G. Kaya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
- (2012) Sinziana Seicean et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications
- (2012) Lei Xi et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Role of antioxidants in cancer therapy
- (2012) Vanessa Fuchs-Tarlovsky NUTRITION
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
- (2012) S. E. Lipshultz et al. PEDIATRICS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
- (2012) Yonggang Ma et al. PLoS One
- Capecitabine (and 5 Fluorouracil) Cardiotoxicity. Metabolic Considerations
- (2011) Chiara Lestuzzi et al. Breast Journal
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity
- (2011) Søren Astrup Jensen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats
- (2011) Bingong Li et al. Cardiovascular Diabetology
- Clinical and Electrocardiography Changes in Patients Treated with Capecitabine
- (2011) Dogan Koca et al. CHEMOTHERAPY
- Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System
- (2011) Babak Nazer et al. CIRCULATION
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- Mechanisms of Antiangiogenic-Induced Arterial Hypertension
- (2011) Jean-Jacques Mourad et al. CURRENT HYPERTENSION REPORTS
- Anthracycline cardiotoxicity
- (2011) Pierantonio Menna et al. Expert Opinion On Drug Safety
- Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved
- (2011) Ashish Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention
- (2011) Patrizia Ferroni et al. REJUVENATION RESEARCH
- Vascular Endothelial Growth Factor Stimulates Endothelial Colony Forming Cells Proliferation and Tubulogenesis by Inducing Oscillations in Intracellular Ca2+ Concentration
- (2011) Silvia Dragoni et al. STEM CELLS
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
- (2011) MARIELE DESSÌ et al. Experimental and Therapeutic Medicine
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunction
- (2010) M. Y. Maslov et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardioprotective Pathways During Reperfusion: Focus on Redox Signaling and Other Modalities of Cell Signaling
- (2010) Pasquale Pagliaro et al. ANTIOXIDANTS & REDOX SIGNALING
- Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications
- (2010) Chiara Nediani et al. ANTIOXIDANTS & REDOX SIGNALING
- Redox-optimized ROS balance: A unifying hypothesis
- (2010) M.A. Aon et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice
- (2010) Chengqun Huang et al. CIRCULATION
- Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
- (2010) Maija Bry et al. CIRCULATION
- Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
- (2010) Michael Kohlhaas et al. CIRCULATION
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses
- (2010) Andrew Jabbour et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect
- (2010) S. Koka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
- (2010) Runlin Gao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
- (2010) Amy V. Pointon et al. PLoS One
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- 5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
- (2010) Koh Miura et al. Cancers
- Intricacies of Bevacizumab-Induced Toxicities and Their Management
- (2009) Sarah M Gressett et al. ANNALS OF PHARMACOTHERAPY
- Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer
- (2009) Giuseppe Aprile et al. ANTI-CANCER DRUGS
- NADPH Oxidases: Functions and Pathologies in the Vasculature
- (2009) Bernard Lassègue et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
- (2009) A. Riad et al. CANCER RESEARCH
- Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
- (2009) Andrey Anisimov et al. CIRCULATION RESEARCH
- Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
- (2009) M. J. Haykowsky et al. CLINICAL CANCER RESEARCH
- Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
- (2009) Risto Kerkela et al. CTS-Clinical and Translational Science
- Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
- (2009) Glenwood D. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein
- (2009) Ioanna Andreadou et al. NMR IN BIOMEDICINE
- Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure
- (2008) Sharad Rastogi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Cardiotoxicity of Antitumor Drugs†
- (2008) Pierantonio Menna et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
- (2008) Filomena de Nigris et al. EUROPEAN JOURNAL OF CANCER
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
- (2008) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure
- (2008) Kris Doggen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
- (2008) Elke Martin et al. TOXICOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now